Table 1.
Clinical characteristics and ophthalmic data of control subjects and patients with central retinal vein occlusion.
| M/F | Age (y) | Diagnosis | Laterality | Underlying diseases | CMT (μm) | BCVA (logMAR) | IOP (mmHg) | SE (D) | miRNA PCR array | Gel zymography | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Control | |||||||||||
| 1 | F | 65 | Cataract | OD | HTN | n/a | 0.30 | 15 | − 1.25 | √ | |
| 2 | F | 63 | Cataract | OD | (–) | n/a | 0.52 | 19 | − 0.25 | √ | |
| 3 | F | 65 | Cataract | OD | (–) | n/a | 0.22 | 16 | 0.00 | √ | |
| 4 | F | 62 | Cataract | OD | (–) | n/a | 0.00 | 17 | − 0.50 | √ | |
| 5 | M | 66 | Cataract | OS | (–) | n/a | 0.30 | 17 | − 4.50 | √ | |
| 6 | F | 65 | Cataract | OD | HTN | n/a | 0.15 | 15 | − 4.50 | √ | |
| 7 | M | 56 | Cataract | OD | (–) | n/a | 0.40 | 15 | − 0.50 | √ | |
| 8 | F | 70 | Cataract | OD | HTN | n/a | 0.10 | 14 | − 0.50 | √ | |
| CRVO | |||||||||||
| 1 | M | 62 | CRVO | OD | HTN, Dyslipidemia | 603 | 0.52 | 12 | 0.50 | √ | |
| 2 | F | 75 | CRVO | OS | HTN, Unstable angina | 567 | 0.30 | 13 | − 0.25 | √ | |
| 3 | F | 63 | CRVO | OS | Dyslipidemia | 802 | 1.00 | 18 | 1.00 | √ | |
| 4 | M | 75 | CRVO | OS | HTN | 550 | 0.70 | 10 | 0.00 | √ | |
| 5 | M | 52 | CRVO | OD | HTN | 657 | 1.10 | 15 | 0.00 | √ | |
| 6 | M | 68 | CRVO | OD | HTN | 836 | 0.30 | 18 | − 0.50 | √ | |
| 7 | M | 76 | CRVO | OD | (–) | 486 | 0.70 | 19 | − 1.00 | √ | |
| 8 | F | 43 | CRVO | OS | (–) | 445 | 0.30 | 11 | − 1.00 | √ | |
| 9 | M | 78 | CRVO | OS | HTN | 629 | 1.00 | 16 | − 1.50 | √ | |
| 10 | F | 61 | CRVO | OD | HTN, Dyslipidemia | 391 | 1.00 | 12 | 0.75 | √ | |
BCVA, Best-corrected visual acuity; CMT, central macular thickness; CRVO, central retinal vein occlusion; HTN, hypertension; IOP, intraocular pressure; n/a, not applicable; SE, spherical equivalent.